Medulloblastoma
Medulloblastoma
Contact Us
Related Videos :
Frequently Asked Questions :
1. What is the prognosis for medulloblastoma?
The prognosis for medulloblastoma depends on several factors, including the tumor subtype, the extent of surgical resection, and the patient’s age. Early diagnosis and treatment significantly improve outcomes.
2. Can medulloblastoma recur after treatment?
Yes, medulloblastoma can recur, particularly if not completely removed during surgery. Regular follow-up appointments and imaging are crucial for early detection of recurrence.
3. Are there any clinical trials for medulloblastoma?
Yes, various clinical trials are underway to explore new treatments and therapies for medulloblastoma. Patients may discuss potential participation with their healthcare team.
About Medulloblastoma
Medulloblastoma is a malignant brain tumor that primarily affects children but can occur in adults as well. It originates in the cerebellum, the part of the brain responsible for coordination and balance. This tumor is classified as a primitive neuroectodermal tumor (PNET) and is one of the most common types of brain tumors in children. Early diagnosis and appropriate treatment are crucial for improving outcomes.
Causes of Medulloblastoma
While the exact cause of medulloblastoma remains unclear, several factors may contribute to its development:
- Genetic Mutations: Certain genetic syndromes, such as Li-Fraumeni syndrome and Turcot syndrome, increase the risk of developing brain tumors.
- Environmental Factors: Exposure to radiation during childhood, particularly to the head, may elevate the risk.
- Age and Gender: Medulloblastoma is more common in children aged 3 to 8 years and shows a slight male predominance.
Types of Medulloblastoma
Medulloblastoma is categorized into four primary subtypes, each with distinct biological characteristics:
- WNT-activated Medulloblastoma: Typically has a favorable prognosis and occurs mainly in younger children.
- SHH-activated Medulloblastoma: Common in infants and adults, with variable prognosis.
- Group 3 Medulloblastoma: Often associated with a poor prognosis and tends to occur in younger males.
- Group 4 Medulloblastoma: The most prevalent subtype, with mixed outcomes and varying responses to treatment.
Symptoms of Medulloblastoma
Symptoms of medulloblastoma can vary based on tumor size and location but may include:
- Headaches, particularly in the morning
- Nausea and vomiting
- Difficulty with coordination and balance
- Changes in behavior or personality
- Seizures
- Vision problems, such as double vision or blurred vision
Diagnosis of Medulloblastoma
Diagnosing medulloblastoma involves a comprehensive evaluation, which includes:
- Neurological Examination: Assessment of cognitive function, coordination, and reflexes.
- Imaging Studies:
- MRI: The primary imaging modality for detecting brain tumors.
- CT Scan: Used to assess the extent of the tumor and surrounding structures.
- Biopsy: A tissue sample may be taken to confirm the diagnosis and determine the tumor type.
Treatment of Medulloblastoma
Treatment for medulloblastoma typically involves a multidisciplinary approach:
- Surgery: The primary treatment is surgical removal of the tumor, aiming for complete resection.
- Radiation Therapy: Adjuvant radiation therapy is often used, particularly for patients with residual disease after surgery.
- Chemotherapy: Post-surgical chemotherapy is commonly administered to eliminate remaining cancer cells and reduce the risk of recurrence.
- Follow-up Care: Regular follow-ups and imaging studies are essential to monitor for recurrence or long-term side effects of treatment.
Cost of Treatment and Stay in India
The cost of medulloblastoma treatment in India varies based on several factors, including the hospital, location, and complexity of care. On average, the estimated cost for surgery, radiation, and chemotherapy may range from $10,000 to $30,000.